“Powering the Quantum future“
- Founding: 2016
- HQ: CA, USA
- Market: Quantum Computing
- Total Funding: $2.8B
- Funding Stage: Series-E
- No. of Employees: 450+
Our firm prepares detailed research reports and investment memos for select private company opportunities. Going beyond our public materials, these reports provide comprehensive analysis including the investment thesis, market and competitive assessment, proprietary alternative data, risks and mitigants, and financial base, bear, and bull scenarios. Our research surfaces key insights to help enable informed investment decisions. The content on this page is provided for educational purposes only and is not an endorsement, sponsorship, affiliation, or investment recommendation of PsiQuantum.
PsiQuantum, founded in 2016 by four quantum physics researchers from the University of Bristol and Imperial College London, is a Palo Alto-based quantum computing company specializing in large-scale, fault-tolerant quantum computers. Known for developing silicon photonic quantum systems capable of over one million qubits, PsiQuantum aims to solve complex problems that would take today’s supercomputers thousands of years to calculate. The company emphasizes scalability and commercial viability in its quantum innovations by leveraging existing semiconductor manufacturing processes rather than creating entirely new production methods. With major investments from institutional investors like BlackRock and substantial government backing from Australia and the United States, PsiQuantum has rapidly grown in prominence and is valued at $7 billion following a landmark $1 billion Series E in September 2025. Backed by nearly $2 billion in private capital plus over $600 million in government funding, PsiQuantum is breaking ground on datacenter-sized Quantum Compute Centers in Brisbane, Australia and Chicago, Illinois, targeting operational utility-scale quantum computers by 2027. The company is driven by the potential for quantum computing to transform trillion-dollar industries like pharmaceuticals, finance, and energy.
• TSG VAULT IS LIVE
your investing partner
Wealth Management – Estate Planning – Tax Strategies – Insurance – Private Markets
Connected, Coordinated, and built around you
Investing in psiquantum — What You Need to Know in 2026
Overview
- psiquantum’s Founding
- What psiquantum Does: Core Products and Services
- How psiquantum Makes Money: The Business Model
- psiquantum’s 2026 Valuation
- Why Consider Investing in psiquantum
- Risks Associated with Investing in psiquantum
- The Future Outlook of psiquantum
- Frequently Asked Questions
- How Can I Invest In psiquantum?
- Is psiquantum Publicly Traded?
- How Can I Buy psiquantum Stock?
- Is It Possible To Invest In psiquantum Through ETFs or Mutual Funds?
Key Highlights
- In February 2025, PsiQuantum unveiled Omega, a quantum photonic chipset purpose-built for utility-scale quantum computing, featured in a paper published in Nature. The chipset integrates high-performance single-photon sources, superconducting single-photon detectors, and next-generation Barium Titanate (BTO) optical switches—all manufactured at GlobalFoundries’ high-volume Fab 8 in Malta, New York. The company demonstrated high-fidelity qubit operations and chip-to-chip quantum interconnects over distances up to 250 meters using standard telecom optical fiber, a key enabler for scaling that remains challenging for competing technologies.
- PsiQuantum’s valuation reached $7 billion in September 2025 following a $1 billion Series E led by BlackRock, Temasek, and Baillie Gifford. New investors included NVentures (NVIDIA’s venture capital arm), Macquarie Capital, Qatar Investment Authority, Counterpoint Global (Morgan Stanley), Ribbit Capital, and others. Total private funding now exceeds $1.8 billion, making PsiQuantum the most well-funded quantum computing company globally. NVIDIA is collaborating with PsiQuantum across quantum algorithms, GPU-QPU integration, and silicon photonics development.
- The company broke ground in 2025 on two datacenter-sized Quantum Compute Centers: one in Brisbane, Australia (backed by AU$940 million from Australian Federal and Queensland State governments) and one in Chicago, Illinois at the Illinois Quantum and Microelectronics Park. PsiQuantum also operates a 120,000 square foot manufacturing and testing facility in Milpitas, California, and a UK R&D facility in Daresbury focused on large-scale cryogenic infrastructure. Target for operational utility-scale systems is 2027.
- DARPA selected PsiQuantum alongside Microsoft for the final validation phase of the Underexplored Systems for Utility-Scale Quantum Computing (US2QC) program in February 2025, following evaluation by over 50 government experts. The Air Force Research Laboratory awarded PsiQuantum a $10.8 million contract in April 2025 for quantum chip capabilities, building on a partnership established in 2022. These government partnerships validate PsiQuantum’s approach and accelerate national security applications.
PsiQuantum’s Founding
In 2016, four quantum physics pioneers made a bold decision that would reshape the landscape of quantum computing. Jeremy O’Brien, Terry Rudolph, Peter Shadbolt, and Mark Thompson—distinguished researchers from the University of Bristol and Imperial College London—established PsiQuantum in Palo Alto, California, with an audacious vision: to build the world’s first commercially viable, fault-tolerant quantum computer capable of solving humanity’s most pressing challenges.
While competitors pursued various quantum technologies, the PsiQuantum founders chose a different approach—silicon photonics. Their key insight was to use the same proven manufacturing methods that already produce computer chips, rather than creating entirely new production processes. This allowed them to build quantum computers with over one million qubits at a scale that other quantum technologies couldn’t match..
This strategic choice proved instrumental in attracting world-class support. Early investors including Playground Global, Redpoint Ventures, and The House Fund recognized the transformative potential of the team’s approach. As PsiQuantum’s technology matured, major institutional investors including BlackRock, Baillie Gifford, Microsoft’s M12 venture fund, Founders Fund, and Temasek joined the mission. The company’s international appeal became evident when both the Australian Commonwealth and Queensland governments committed substantial public sector investment. By mid-2025, PsiQuantum had successfully raised approximately $2.1 billion across multiple funding rounds, including a $450 million Series D in 2021, a landmark $617 million Australian government partnership in 2024, and a $750 million Series E round in 2025. The company has also cultivated strategic partnerships with leading technology firms, semiconductor manufacturers—most notably GlobalFoundries—and research institutions worldwide, providing access to advanced manufacturing capabilities that accelerate the path to commercial quantum computing.
Today, PsiQuantum stands as a leader in the global race to achieve quantum advantage, with their focus on scalable, manufacturable quantum systems addressing real-world challenges across pharmaceuticals, finance, energy, and climate science. Their journey from academic research to a multi-billion-dollar quantum computing company illustrates how visionary thinking, strategic partnerships, and patient capital can converge to tackle humanity’s most complex challenges.
Explore quantum computing – a transformative technology shaping our future and one of our future tech portfolio strategies.
• TSG VAULT IS LIVE
want access to live opportunities?
Enter TSG Vault to view current fund offerings, pricing data, and connect with an advisor.
What PsiQuantum Does: Core Products and Services
PsiQuantum is building the world’s first large-scale, fault-tolerant quantum computer using silicon photonics technology. The company’s flagship quantum computing platform is designed to deliver at least one million physical qubits—the scale necessary to achieve practical quantum advantage for solving real-world problems. By using standard semiconductor manufacturing processes and partnering with leading foundries like GlobalFoundries, PsiQuantum ensures both scalability and reliability in production. The quantum computing system features a modular, silicon photonic architecture that integrates quantum circuits directly onto silicon wafers. This design enables mass production with high manufacturing yields while remaining compatible with existing semiconductor supply chains. The technology roadmap focuses on delivering error-corrected quantum computers capable of solving problems beyond the reach of today’s most powerful classical supercomputers.
Simply put, PsiQuantum is building an extraordinarily powerful new type of computer that works completely differently from today’s computers. While your laptop might have billions of regular computing bits, PsiQuantum’s quantum computer will have over one million “qubits“—special quantum bits that can process information in ways that make certain calculations exponentially faster. The key breakthrough is that they’re building these quantum computers using the same factories and processes that make regular computer chips, which means they can actually manufacture them at scale rather than building one-off laboratory experiments. This approach allows them to create quantum computers powerful enough to solve problems that would take today’s best supercomputers thousands of years to figure out.
PsiQuantum targets high-impact industries including pharmaceuticals, climate science, finance, energy, and logistics. The company develops quantum algorithms and software tools specifically tailored for these sectors, enabling applications in drug discovery, materials science, optimization, and cryptography. Beyond hardware, PsiQuantum provides access to its quantum systems through early access programs and collaborative partnerships, allowing enterprises and research institutions to co-develop applications and validate quantum solutions.
Omega Quantum Photonic Chipset
Unveiled in February 2025 and featured in Nature, the Omega chipset represents a breakthrough in manufacturable quantum hardware. Designed by PsiQuantum and manufactured at GlobalFoundries’ Fab 8 in New York, Omega integrates all advanced components required for million-qubit-scale quantum computers: high-performance single-photon sources, superconducting single-photon detectors using thin-film materials, and BTO-based electro-optic phase shifters for low-loss, high-speed optical switching. PsiQuantum manufactures 300mm BTO wafers at its California facilities, which are integrated with GlobalFoundries wafers. The company has characterized millions of devices on thousands of wafers, performing approximately 500,000 measurements monthly—achieving yields comparable to standard semiconductor manufacturing.
Quantum Compute Centers and Infrastructure
PsiQuantum is constructing two datacenter-sized Quantum Compute Centers targeting operational status by 2027. The Brisbane, Australia facility, backed by AU$940 million ($620 million USD) from Australian Federal and Queensland State governments, will house utility-scale quantum computers near Brisbane Airport. The Chicago facility at the Illinois Quantum and Microelectronics Park represents America’s first million-qubit scale, fault-tolerant quantum computer site. PsiQuantum’s 120,000 square foot manufacturing and testing facility in Milpitas, California serves as the primary systems integration hub. The UK Daresbury Laboratory focuses on next-generation high-power cryogenic modules. A partnership with Linde Engineering announced in May 2025 will deliver the largest cryogenic plant ever planned for a quantum computer.
Software and Algorithm Tools
In September 2025, PsiQuantum launched Construct, a software tool for designing and optimizing fault-tolerant quantum algorithms. Integrated with PsiQuantum’s proprietary compiler, Construct generates executable circuit tapes ready for fabrication on the Omega chipset. The company also released open-source projects QREF and Bartiq in May 2024, providing libraries, tools, and datasets for benchmarking and optimizing quantum circuits. These tools enable large-scale algorithm design for applications including quantum chemistry, factoring, and optimization problems.
• TSG VAULT IS LIVE
want access to live opportunities?
Enter TSG Vault to view current fund offerings, pricing data, and connect with an advisor.
How PsiQuantum Makes Money: The Business Model
PsiQuantum’s business model focuses on three main revenue streams:
- selling quantum computing systems
- partnering with enterprises and governments for early access
- co-development projects, and providing quantum computing services and software solutions.
The company targets customers in industries where quantum computing can deliver breakthrough value, including pharmaceuticals, finance, energy, climate science, healthcare, logistics, and aerospace.
The company’s manufacturing-first approach leverages partnerships with semiconductor manufacturers like GlobalFoundries to produce quantum computers using established chip fabrication infrastructure. This strategy enables mass production and reliability while delivering utility-scale quantum computers with over one million physical qubits. PsiQuantum may be positioned to capture significant market share in the rapidly growing quantum computing sector by focusing on high-impact applications such as drug discovery, financial risk modeling, energy grid optimization, and climate system modeling.
BTO-enabled optical switches also have potential applications in next-generation AI supercomputers, where low-power, high-speed optical networking is increasingly relevant given rapidly-growing AI workloads. This positions PsiQuantum for near-term revenue opportunities in adjacent markets while utility-scale quantum systems are under development.
Currently, PsiQuantum is in a heavy investment phase, directing substantial resources toward R&D and infrastructure development. The company expects to begin generating commercial revenue as its quantum systems demonstrate practical utility and quantum advantage in real-world applications. This long-term approach reflects the company’s commitment to building scalable, commercially viable quantum computing solutions that address critical challenges across multiple industries.
PsiQuantum’s 2026 Valuation
PsiQuantum’s 2026 valuation reflects diverse pricing inputs, including the company’s most recent funding round, current fund valuations, and secondary market transactions.
PsiQuantum has achieved one of the most impressive fundraising trajectories in quantum computing, raising over $2.1 billion since its founding in 2016. The company’s valuation more than doubled from $3.15 billion in July 2021 to $7 billion in September 2025, reflecting potentially strong investor confidence in its silicon photonics approach and progress toward commercial quantum computing.
The funding journey began with a $1.5 million seed round in January 2016 and culminated in a $750 million Series E (2025) led by BlackRock. The company also secured significant public sector investment, including the landmark $617 million package from the Australian and Queensland governments in 2024.
Key investors include BlackRock, Baillie Gifford, Microsoft’s M12, Temasek, Founders Fund, Atomico, Playground Global, and Redpoint Ventures. This diverse investor base combines top-tier venture capital with strategic corporate investment and government backing, possibly positioning PsiQuantum as a global leader in the race to deliver commercially viable quantum computing solutions.
The company’s rapid valuation growth reflects its unique manufacturing-first approach using established semiconductor processes, targeting high-value markets in pharmaceuticals, finance, energy, and climate science. As quantum computing moves from laboratory research toward practical applications, PsiQuantum’s scalable technology platform and substantial funding may position it to capture significant market share in what analysts project will become a multi-billion dollar industry.
• TSG VAULT IS LIVE
want access to live opportunities?
Enter TSG Vault to view current fund offerings, pricing data, and connect with an advisor.
Why Consider Investing In PsiQuantum
The information provided is intended for educational and informational purposes only. This does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Investment decisions should be made in consultation with a qualified financial professional who can assess your personal circumstances and objectives. Past performance does not guarantee future results, and all investing involves risk of loss.
Revolutionary Technology
PsiQuantum may have cracked the code on quantum computing’s biggest challenge: scalability. The February 2025 Omega chipset, featured in Nature, demonstrates all components required for million-qubit systems manufactured at semiconductor-industry scale and yields. While competitors struggle with small-scale prototypes, PsiQuantum’s silicon photonics approach leverages existing chip manufacturing infrastructure at GlobalFoundries’ high-volume fab to build million-qubit systems. Demonstrated 250-meter chip-to-chip quantum interconnects using standard telecom fiber provide a clear path to system scaling.
Successful Financial Foundation
With over $2.1 billion raised from world-class investors including BlackRock and substantial government backing from Australia and the U.S., PsiQuantum may have the financial runway to execute its ambitious vision. This level of institutional support—both private and public—demonstrates unprecedented confidence in the company’s approach and market potential.
Strategic Market Positioning
PsiQuantum targets trillion-dollar problems in pharmaceuticals, finance, energy, and climate science—industries where quantum advantage could unlock massive value. The company’s partnerships with GlobalFoundries and other technology leaders provide access to advanced manufacturing capabilities and accelerate the path to market, positioning PsiQuantum to potentially capture a significant share of the emerging quantum computing market.
Substantial Market Potential
Quantum computing is expected to disrupt industries such as pharmaceuticals, finance, energy, and logistics. PsiQuantum’s focus on utility-scale systems may position it to capture significant value as the market matures and practical quantum advantage is achieved
• TSG VAULT IS LIVE
want access to live opportunities?
Enter TSG Vault to view current fund offerings, pricing data, and connect with an advisor.
PsiQuantum Risk Factors
Note: This information is for informative purposes only and is not investment advice or a recommendation.
Investors considering investing in PsiQuantum should weigh the company’s significant potential against key risk factors. While PsiQuantum demonstrates technological leadership and strong market positioning, its pre-revenue status, current unprofitability, and substantial investments in quantum hardware development warrant careful consideration. The company’s current valuation anticipates significant future expansion, yet mounting competition in the quantum computing sector from tech giants like Google, IBM, and Microsoft, as well as emerging quantum startups, could impact revenue potential and profit margins.
Before investing in PsiQuantum, potential investors should evaluate several critical risks and challenges (the following examples do not encompass all potential investment risks):
Unproven Technology
Quantum computing remains largely experimental, and no company has yet delivered a truly fault-tolerant system at commercial scale. PsiQuantum’s ambitious million-qubit target represents a massive technological leap that may encounter unforeseen technical barriers or take significantly longer than projected to achieve.
Extended Timeline to Profitability
PsiQuantum operates with substantial cash burn and no current revenue stream, requiring continued massive investment in R&D and infrastructure. The path from prototype to profitable commercial product could span many years, during which the company remains financially vulnerable and dependent on continued investor support.
Fierce Competition in a Winner-Take-All Market
Tech giants like Google, IBM, and Microsoft are pouring billions into quantum computing research, while numerous well-funded startups pursue alternative approaches. A breakthrough by competitors or a fundamental shift in the preferred quantum technology could quickly erode PsiQuantum’s advantages and market position.
Capital-Intensive Business Model
Building quantum computers requires enormous ongoing investment in specialized manufacturing, research facilities, and talent. Economic downturns, changing investor priorities, or reduced government funding could limit access to the capital needed to execute PsiQuantum’s roadmap, potentially allowing competitors to overtake the company.
Explore quantum computing – a transformative technology shaping our future and one of our future tech portfolio strategies.
The Future Outlook of PsiQuantum
The quantum technology market represents a massive opportunity, with projections ranging from $16 billion to $37 billion by 2030. The company’s silicon photonics approach may position it to capture significant value as quantum computing transitions from experimental research to commercial reality across multiple trillion-dollar industries. The September 2025 Series E provides capital to break ground on Quantum Compute Centers in Brisbane and Chicago, with operational targets by 2027. The Omega chipset’s Nature publication and DARPA’s validation-phase selection demonstrate technology maturity beyond laboratory prototypes.
The financial services sector may represent PsiQuantum’s most immediate and lucrative opportunity. Banks and financial institutions are already investing heavily in quantum capabilities for risk modeling, portfolio optimization, fraud detection, and next-generation security. PsiQuantum’s million-qubit target directly addresses the computational scale needed to deliver transformative advantages in these applications, potentially unlocking billions in new revenue for early adopters.
Beyond finance, PsiQuantum’s technology roadmap aligns with emerging market demands across pharmaceuticals, energy, and climate science. The company’s partnerships with semiconductor foundries like GlobalFoundries provide a crucial manufacturing advantage, enabling mass production when competitors remain limited to laboratory prototypes. This scalability advantage becomes increasingly valuable as quantum applications move from proof-of-concept to production deployment. Several converging trends may favor PsiQuantum’s long-term prospects. The integration of quantum computing with artificial intelligence promises to accelerate breakthrough discoveries in drug development and materials science. Growing cybersecurity threats are driving demand for quantum-safe encryption solutions. Meanwhile, the shift toward hybrid quantum-classical workflows creates new opportunities for cloud-based quantum services.
PsiQuantum’s substantial funding, strategic partnerships**, and government validation** may position the company to capitalize on these trends as quantum computing evolves from a speculative technology to an essential business tool. With NVIDIA collaboration on GPU-QPU integration, Linde Engineering building the world’s largest quantum cryogenic plant, and datacenter-sized facilities under construction on two continents, success in delivering the first commercially viable, utility-scale quantum computer could establish PsiQuantum as a dominant force in multiple high-value markets, potentially generating returns that justify today’s $7 billion valuation.
Be sure to read the full disclaimer below prior to considering any investment in PsiQuantum.
Frequently Asked Questions
Any mention of PsiQuantum in the FAQs does not imply that we offer opportunities in PsiQuantum to investors or have invested in PsiQuantum directly. We may or may not own a position in PsiQuantum, we may or may not provide PsiQuantum opportunities to investors, or both. Any mention of TSG Capital Advisors, TSG Invest funds, or any other TSG Invest-affiliate is for purposes of addressing the questions and does not imply that we have access to or recommend PsiQuantum as an investment.
The information provided is intended for educational and informational purposes only. This does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Investment decisions should be made in consultation with a qualified financial professional who can assess your personal circumstances and objectives. Past performance does not guarantee future results, and all investing involves risk of loss.
How can I Invest In PsiQuantum?
Investing in PsiQuantum stock typically requires accredited investor status. The process of buying PsiQuantum stock can be complex, influenced by factors like the availability of shares, the management team’s openness to adjusting the PsiQuantum ownership structure (cap table adjustments), and meeting minimum investment requirements. At TSG Invest, we specialize in facilitating PsiQuantum private investment opportunities. Through our affiliates, we provide accredited investors with options to acquire PsiQuantum stock directly via TSG Capital Advisors or explore ways to invest in PsiQuantum indirectly through pooled investment vehicles managed by our experienced fund managers. Discover streamlined access to PsiQuantum private investment opportunities with TSG Invest.
Is PsiQuantum Publicly Traded?
PsiQuantum is a privately held company, and its shares are not available for purchase on public exchanges. Investors can either buy PsiQuantum stock via a pre-IPO broker like TSG Capital Advisors or invest in PsiQuantum indirectly through pooled investment vehicles, such as those managed by TSG Invest fund managers.
How Can I Buy PsiQuantum Stock?
PsiQuantum stock is only available via pre-IPO brokers and private market marketplaces. A pre-IPO broker, like TSG Capital Advisors (an affiliate of TSG Invest), can help accredited investors learn more information about investing in PsiQuantum and buying PsiQuantum stock, including the PsiQuantum stock price, the latest news about PsiQuantum going public, and ways to invest in PsiQuantum indirectly. Examples include investing in PsiQuantum via pooled investment vehicles managed by TSG Invest fund managers.
When Will PsiQuantum IPO?
As of 2026, it is unknown when PsiQuantum will go public. The company’s $7 billion valuation following the September 2025 Series E, combined with its capital-intensive infrastructure buildout targeting 2027 operational systems, suggests the company has substantial runway before requiring public market capital. The DARPA validation phase extending through 2033 and utility-scale facilities under construction indicate a multi-year development timeline before commercial revenue generation would support traditional IPO metrics. While many investors anticipate an PsiQuantum IPO, it’s crucial to understand that an IPO is not the only type of liquidity event available for private companies. While much attention focuses on the possibility of PsiQuantum going public, other potential outcomes include acquisition or merger with another company. When evaluating an PsiQuantum IPO or similar venture-backed private companies, investors should also consider less favorable scenarios, such as the company remaining private or facing business challenges. Stay informed about updates on an PsiQuantum IPO and other potential liquidity outcomes.
Is It Possible To Invest In PsiQuantum Through ETFs or Mutual Funds?
Investing in PsiQuantum through an ETF or mutual fund is often not possible, as private investment opportunities in PsiQuantum are generally not available via these channels. However, in cases where you can invest in PsiQuantum through an ETF or mutual fund, it’s important to note that you won’t have the option to purchase PsiQuantum stock directly. Additionally, investors typically have no control over share management, and the fund’s portfolio may include other holdings, potentially diluting exposure to PsiQuantum. To explore options for buying PsiQuantum stock directly or alternative ways to invest in PsiQuantum, contact TSG Invest today.
TSG Invest is the brand name of The Spaventa Group LLC, a multi-entity financial services holding company founded in 2020 and headquartered on Long Island, New York. Through its affiliated entities — TSG Alpha Partners LLC (SEC-registered investment adviser), TSG Capital Advisors LLC (FINRA-registered broker-dealer, member SIPC), TSG Fund Management, and TSG Insurance Services LLC — TSG Invest provides family office-style wealth management, alternative investments, pre-IPO venture capital access, structured notes, hedging strategies, custom indexing, insurance solutions, and more. TSG Invest’s proprietary Venture 50 Index and TSG Vault platform provide investors with research, analysis, and access to opportunities in the pre-IPO market. Learn more about TSG Invest and our affiliated entities.
IMPORTANT DISCLAIMER FOR INVESTORS CONSIDERING INVESTING IN PSIQUANTUM
The following material is provided by TSG Invest and its affiliates (collectively “TSG Invest”) for informational and educational purposes only. This material does not constitute an offer to sell securities or a solicitation to participate in any trading strategy. Investing inherently involves risk, including the potential loss of principal. Past performance does not guarantee future results, and market conditions can change rapidly. Different investments carry varying levels of risk. While content is compiled from sources believed reliable, TSG Invest cannot guarantee complete accuracy or completeness of information presented. All opinions, forecasts, and projections reflect our views as of the publication date. This material may contain preliminary information and forward-looking statements. Due to various factors, actual events may differ substantially from those presented. TSG Invest assumes no obligation to update forward-looking statements or opinions. TSG Invest, its officers, directors, employees, or clients may hold positions in mentioned securities or investments. Such positions may change at any time without notice. All opinions and market views are subject to change without notice. TSG Invest and its financial advisors do not provide legal, tax, or accounting advice. You should consult with legal and tax advisors before making any financial decisions. This material does not consider individual investment objectives, financial situations, or needs. Furthermore, TSG Invest does not monitor ongoing suitability, provide personalized recommendations without a formal agreement, or determine if content suits individual readers. Receipt of this material does not create an advisory relationship. Professional financial advice is recommended for your specific situation. Investors should carefully review all risks and consider their investment objectives, resources, and risk tolerance before making investment decisions. No assurance can be given that any specific investment or strategy will be profitable or suitable for any specific investor’s portfolio. Asset allocation, rebalancing, and diversification strategies do not guarantee against risk in broadly declining markets. This material is not intended as a recommendation, offer, or solicitation for the purchase or sale of any security or investment strategy. TSG Invest (d/b/a of The Spaventa Group LLC) is not a registered broker-dealer nor investment advisor. TSG Invest refers certain financial services to its affiliated broker-dealer, TSG Capital Advisors LLC (“TSGCA”) (Member FINRA/SIPC), its wholly owned registered investment advisor subsidiary, TSG Alpha Partners LLC (“TSGA”), and its wholly owned insurance agency subsidiary, TSG Insurance Services LLC (“TSGIS”). Financial Planning and Investment Advisory Services offered through TSG Alpha Partners LLC (CRD #319493). Private placements offered through TSG Capital Advisors (CRD #147509), member FINRA, SIPC. Insurance products offered through TSG Insurance Services LLC. TSG Alpha Partners, TSG Capital Advisors, and TSG Insurance Services are affiliated due to common ownership. These affiliates may take positions contrary to those discussed in this material. Private placements discussed herein are especially high-risk and illiquid investments typically only available to accredited investors under Regulation D. These securities are subject to holding period requirements, and not all private companies will succeed or go public. Independent due diligence is essential, and investors should be prepared for the possibility of total loss of investment.
RISK FACTORS RELATED TO QUANTUM TECHNOLOGY INVESTMENTS
Investments in companies developing or utilizing quantum technologies are subject to significant risks that could result in the loss of some or all of your investment. Quantum technologies are in early developmental stages and face substantial technological, regulatory, and commercial uncertainties. Companies in this sector may be adversely affected by the extreme technical challenges of quantum systems, including quantum decoherence, error rates, and the need for ultra-low temperature operating environments. Quantum systems are highly sensitive to environmental interference and require specialized infrastructure and expertise to maintain stable operations. The quantum technology sector faces fundamental scalability challenges. Current quantum computers have limited qubit counts and high error rates that restrict practical applications. Companies may struggle to achieve quantum advantage over classical computing systems, and the timeline for commercially viable quantum applications remains highly uncertain. The transition from laboratory demonstrations to real-world applications may take significantly longer than anticipated or may not occur at all. Quantum technologies require substantial ongoing investment in specialized equipment, facilities, and materials. The costs of quantum hardware, including dilution refrigerators, specialized control systems, and clean room facilities, are extremely high. Companies may face difficulties securing adequate funding for the extended research and development periods required before generating revenue. The quantum supply chain is limited and concentrated among few suppliers, creating potential bottlenecks and cost volatility. The quantum regulatory landscape is nascent and evolving. National security considerations around quantum computing, particularly quantum cryptography and its potential to break current encryption methods, may result in export controls, licensing requirements, or restrictions on international collaboration. Companies may face limitations on their ability to operate in certain markets or access critical technologies due to geopolitical tensions and national security policies. Competition in quantum technology includes not only private companies but also significant government and academic research programs with substantial funding. Established technology companies with vast resources may enter the quantum market and outcompete smaller specialized firms. The quantum talent pool is extremely limited, with fierce competition for quantum physicists, engineers, and specialized technicians. Loss of key personnel could severely impact development capabilities. Market adoption of quantum technologies faces significant barriers. Potential customers may lack the technical expertise to implement quantum solutions or may be reluctant to invest in unproven technologies. The quantum software ecosystem is underdeveloped, limiting practical applications. Companies may struggle to demonstrate clear value propositions over existing classical solutions. Intellectual property protection in quantum technologies presents unique challenges due to the highly specialized nature of the field and the involvement of academic institutions and government research programs. Companies may face patent disputes or may be unable to adequately protect their quantum innovations. The potential for quantum computing to render current cybersecurity measures obsolete could create liability issues for companies whose quantum technologies are used in security applications. Market valuations of quantum companies may be driven by speculation and hype rather than near-term commercial prospects, potentially leading to volatile trading prices that do not reflect underlying business fundamentals. The long development timelines and uncertain commercial viability of quantum technologies make traditional valuation methods difficult to apply. These risk factors are not exhaustive, and other unknown or unpredictable factors could also have material adverse effects on the performance of quantum technology investments.
• TSG VAULT IS LIVE
want access to live opportunities?
Enter TSG Vault to view current fund offerings, pricing data, and connect with an advisor.